mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.4 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.4 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.4 |